Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyue Ding

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Cureus|May 12, 2020
Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival AnalysisGlenn Bauman, Keyue Ding, Joseph Chin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetingsChristopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trialRaymond W Jang, Aurélie Le Maître, Keyue Ding, et al.
Oncotarget|July 30, 2016
Validation of a multi-omics strategy for prioritizing personalized candidate driver genesLi Liang, Liting Song, Yi Yang, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Cancers|July 26, 2020
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet ChemotherapyDesirée Hao, Arjun Sengupta, Keyue Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literatureNaveed Alam, Frances A Shepherd, Timothy Winton, et al.
Scientific Reports|December 4, 2015
Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept StudyKeyue Ding, Songfeng Wu, Wantao Ying, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Cureus|May 12, 2020
Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival AnalysisGlenn Bauman, Keyue Ding, Joseph Chin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetingsChristopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trialRaymond W Jang, Aurélie Le Maître, Keyue Ding, et al.
Oncotarget|July 30, 2016
Validation of a multi-omics strategy for prioritizing personalized candidate driver genesLi Liang, Liting Song, Yi Yang, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Cancers|July 26, 2020
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet ChemotherapyDesirée Hao, Arjun Sengupta, Keyue Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literatureNaveed Alam, Frances A Shepherd, Timothy Winton, et al.
Scientific Reports|December 4, 2015
Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept StudyKeyue Ding, Songfeng Wu, Wantao Ying, et al.
Pageof 16